Literature DB >> 34063858

Mature and Immature/Activated Cells Fractionation: Time for a Paradigm Shift in Differential Leucocyte Count Reporting?

Rana Zeeshan Haider1,2, Najeed Ahmed Khan3, Eloisa Urrechaga4, Tahir Sultan Shamsi2.   

Abstract

Leucocytes, especially neutrophils featuring pro- and anti-cancerous characteristics, are involved in nearly every stage of tumorigenesis. Phenotypic and functional differences among mature and immature neutrophil fractions are well reported, and their correlation with tumor progression and therapy has emerging implications in modern oncology practices. Technological advancements enabled modern hematology analyzers to generate extended information (research parameters) during complete blood cell count (CBC) analysis. We hypothesized that neutrophil and lymphocyte fractions-related extended differential leucocytes count (DLC) parameters hold superior diagnostic utility over routine modalities. The present study was carried out over a four-and-a-half-year period wherein extended neutrophil (immature granulocyte [IG] and mature neutrophil [NEUT#&]), and lymphocyte (activated/high fluorescence lymphocyte count [HFLC] and resting lymphocyte [LYMP#&]) parameters were challenged over routine neutrophil [NEUT#] and lymphocyte [LYMP#] items in a study population of 1067 hematological neoplasm patients. Extending the classical statistical approaches, machine-learning-backed data visualization was used to explore trends in the study parameters. As a whole, extended neutrophil and lymphocyte count outperformed and was diagnostically more relevant than routine neutrophil and lymphocyte parameters by showing the least difference from their respective (gold-standard) manual DLC counts. The mature neutrophil count was compared to IG, and resting lymphocyte count was compared to HFLC by calling the function 'correlation' as a 'clustering function' for heatmap based visualization. The aforementioned study parameters displayed close clustering (rearrangement) for their respective study items by presenting distinct trends of equally valuable weights (deviated values), advocating fractions-based extended DLC reporting. Importantly, using a Bland and Altman analysis analogously to a manual neutrophil count, the mature neutrophil count [NEUT#&] remained unbiased since a routine neutrophil count [NEUT#] was found to be a negatively biased. The extended DLC-parameter-driven fractions-based reporting has superior diagnostic utility over classical routine approaches; this finding can largely minimize labor-intensive manual DLC practices, especially in hematology-oncology departments.

Entities:  

Keywords:  CBC; HFLC; IG; LYMP#&; NEUT#&; extended differential leucocyte count; hematology analyzer

Year:  2021        PMID: 34063858     DOI: 10.3390/diagnostics11060922

Source DB:  PubMed          Journal:  Diagnostics (Basel)        ISSN: 2075-4418


  23 in total

1.  New parameters available on Sysmex XE-5000 hematology analyzers contribute to differentiating dengue from leptospirosis and enteric fever.

Authors:  A Oehadian; M Michels; Q de Mast; D Prihatni; M Puspita; Y Hartantri; S Sinarta; A J A M van der Ven; B Alisjahbana
Journal:  Int J Lab Hematol       Date:  2015-09-03       Impact factor: 2.877

2.  Measurement of granulocyte maturation may improve the early diagnosis of the septic state.

Authors:  Larry H Bernstein; James Rucinski
Journal:  Clin Chem Lab Med       Date:  2011-09-21       Impact factor: 3.694

Review 3.  Identification and quantification of high fluorescence-stained lymphocytes as antibody synthesizing/secreting cells using the automated routine hematology analyzer XE-2100.

Authors:  J Linssen; V Jennissen; J Hildmann; E Reisinger; J Schindler; G Malchau; A Nierhaus; K Wielckens
Journal:  Cytometry B Clin Cytom       Date:  2007-05       Impact factor: 3.058

4.  Automated analysis of differentiation-induced leukemic cells during all-trans retinoic Acid therapy of acute promyelocytic leukemia.

Authors:  Kaoru Tohyama; Shuichi Shiga; Hiroyuki Fujimoto; Yukio Hamaguchi; Satoshi Ichiyama
Journal:  Arch Pathol Lab Med       Date:  2003-01       Impact factor: 5.534

5.  Extended leukocyte differential count and C-reactive protein in septic patients with liver impairment: diagnostic approach to evaluate sepsis in intensive care unit.

Authors:  Sabrina Buoro; Tommaso Mecca; Giovanna Azzarà; Sara Apassiti Esposito; Michela Seghezzi; Mauro Vavassori; Alberto Crippa; Gianmariano Marchesi; Enrico Castellucci; Cosimo Ottomano; Giuseppe Lippi
Journal:  Ann Transl Med       Date:  2015-10

6.  Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas.

Authors:  Isabelle Ray-Coquard; Claire Cropet; Martine Van Glabbeke; Catherine Sebban; Axel Le Cesne; Ian Judson; Olivier Tredan; Jaap Verweij; Pierre Biron; Inthidar Labidi; Jean-Paul Guastalla; Thomas Bachelot; David Perol; Sylvie Chabaud; Pancras C W Hogendoorn; Philippe Cassier; Armelle Dufresne; Jean-Yves Blay
Journal:  Cancer Res       Date:  2009-06-23       Impact factor: 12.701

Review 7.  Roles of neutrophils in cancer growth and progression.

Authors:  Maria Rosaria Galdiero; Gilda Varricchi; Stefania Loffredo; Alberto Mantovani; Gianni Marone
Journal:  J Leukoc Biol       Date:  2017-12-15       Impact factor: 4.962

8.  Performance Evaluation of High Fluorescence Lymphocyte Count: Comparability to Atypical Lymphocyte Count and Clinical Significance.

Authors:  Chaicharoen Tantanate; Cherdsak Klinbua
Journal:  Lab Med       Date:  2018-10-11

Review 9.  The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis.

Authors:  M J M Gooden; G H de Bock; N Leffers; T Daemen; H W Nijman
Journal:  Br J Cancer       Date:  2011-05-31       Impact factor: 7.640

10.  The diagnostic and prognostic significance of monitoring blood levels of immature neutrophils in patients with systemic inflammation.

Authors:  Tracey Anne Mare; David Floyd Treacher; Manu Shankar-Hari; Richard Beale; Sion Marc Lewis; David John Chambers; Kenneth Alun Brown
Journal:  Crit Care       Date:  2015-02-25       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.